Subcutaneous

Related by string. subcutaneous * * subcutaneous formulation . subcutaneous injection . subcutaneous adipose tissue . subcutaneous emphysema . RELISTOR subcutaneous injection . subcutaneous RELISTOR . RELISTOR methylnaltrexone bromide subcutaneous . methylnaltrexone bromide subcutaneous injection . subcutaneous injections . subcutaneous tissue . via subcutaneous injections *

Related by context. All words. (Click for frequent words.) 71 Single Dose 71 Intramuscular 70 Patients Treated 70 Prolongs Survival 69 Well Tolerated 69 Unfractionated Heparin 69 intravesical 68 Investigational Agent 68 Melphalan 68 Monotherapy 68 Low Dose 68 Nebulized 67 Pharmacokinetic Study 67 Pharmacodynamics 67 Pegylated 67 Elderly Patients 67 Patients Undergoing 67 Phase IIb Trial 67 Fixed Dose 67 Radiofrequency Ablation RFA 67 Patients Treated With 67 Dosing Regimen 67 Peginterferon 67 Intravesical 67 Enoxaparin 66 Complicated Skin 66 Chemoradiation 66 Capecitabine 66 Nilotinib 66 Pegylated Liposomal Doxorubicin 66 Mycophenolate Mofetil 66 Antiviral Activity 66 Prophylaxis 66 Recombinant Human 66 Prophylactic 66 Meets Primary Endpoint 66 Patency 66 Dose Ranging Study 66 Decitabine 66 Phase III Clinical Trial 66 Pivotal Phase III 66 Oral Fingolimod 66 Progenitor Cells 66 Patients Receiving 66 Clinical Efficacy 66 Peginterferon Alfa 2a 66 Long Term Efficacy 66 Fondaparinux 66 Extended Release 66 Intravenous IV 66 Fluorouracil 66 Phase 2b Study 65 subcutaneous SC 65 Sevelamer 65 Phase 2b Clinical Trial 65 Relapsing Multiple Sclerosis 65 Ranolazine 65 Rheumatoid Arthritis Patients 65 mitomycin C 65 Statin Therapy 65 Survival Benefit 65 Glatiramer Acetate 65 Cyclosporine 65 Liposomal 65 Intravascular 65 Improves Survival 65 Phase 2b Trial 65 Adjuvant Chemotherapy 65 Infected Patients 65 Appears Safe 65 Investigational Compound 65 Sipuleucel T 65 Double Blind Randomized 65 Mesalamine 65 Intra arterial 65 Intracoronary 65 Postmenopausal Osteoporosis 65 Previously Treated 65 Antitumor Activity 65 5 Fluorouracil 65 fosbretabulin 65 Intrathecal 65 Kidney Transplant Recipients 65 Bare Metal Stent 65 Non Responders 65 Prospective Randomized Trial 65 Randomized Clinical Trial 65 Significantly Reduced 65 Interferon Beta 65 II Clinical Trial 65 PEGylated anti 65 NAVISTAR R 65 Study Evaluating 65 Improves Outcomes 64 Infliximab 64 Clinical Trial Results 64 Clinical Trial Evaluating 64 Cyclophosphamide 64 Dual Antiplatelet Therapy 64 Haemophilus b Conjugate 64 Bare Metal Stents 64 Androgen Deprivation Therapy 64 Receptor Antagonists 64 Pivotal Trial 64 Epoetin Alfa 64 Efficacious 64 Tacrolimus 64 Intranasal 64 Severe Sepsis 64 Placebo Controlled Trial 64 Trastuzumab 64 Hormone Refractory Prostate Cancer 64 Fluconazole 64 Anti TNF 64 Intraperitoneal 64 Phase 2a Clinical Trial 64 Localized Prostate Cancer 64 Overactive Bladder 64 Castration Resistant Prostate Cancer 64 Posaconazole 64 Pemetrexed 64 Phospholipase A2 64 Metastatic Colorectal Cancer 64 alfa 2a 64 Itraconazole 64 Diabetic Neuropathy 64 Preclinical Data 64 Hemolysis 64 Eculizumab 64 Intradermal 64 Autologous 64 Adjunctive Therapy 64 Prostatic 64 nimodipine 64 Relapsing Remitting Multiple Sclerosis 64 Is Well Tolerated 64 Irinotecan 64 Known hypersensitivity 64 Mucosal 64 Hypertensive Patients 64 Occlusion 64 Bosutinib 64 Autologous Stem Cell Transplantation 64 Hepatitis C Genotype 64 Bevacizumab 64 Pediatric Patients 64 Phase III Trial 64 Anti Tumor Activity 64 INTEGRILIN R 64 Treated Patients 64 Treatment Naïve Patients 64 Improve Survival 64 Controlled Trial 64 Methylnaltrexone 64 Percutaneous 64 Skeletal Muscle 64 Immune Responses 64 Bortezomib 64 Zoledronic Acid 64 Antifungal 64 Pharmacokinetics PK 64 Catheter Ablation 64 Bivalirudin 64 Radiofrequency Ablation 64 Paraplatin ® 64 Combination Treatment 64 subcutaneous 64 administered subcutaneously 64 metastatic malignant 64 Lamotrigine 64 See CLINICAL PHARMACOLOGY 64 Fluticasone 64 ACE Inhibitors 64 Hemodialysis Patients 63 Etanercept 63 subcutaneously 63 Humanized Anti 63 Immunosuppression 63 Pegylated Interferon 63 Cilostazol 63 Chronic Pelvic Pain 63 Prospective Randomized 63 TAXOTERE R 63 Renal Impairment 63 Novel Inhibitor 63 Interferon Gamma 63 Refractory Hodgkin Lymphoma 63 Aliskiren 63 Demonstrates Efficacy 63 Epratuzumab 63 Antitumor 63 Prophylactic Treatment 63 Renal Cell Carcinoma 63 Advanced Renal Cell 63 Colorectal Cancer Patients 63 intraperitoneal 63 Pneumococcal Vaccine 63 Investigational Drug 63 Renal Function 63 intradermal injection 63 saline placebo 63 Acute Ischemic Stroke 63 Tyrosine Kinase Inhibitor 63 Ziprasidone 63 Fungal Infections 63 Novel Antibiotic 63 Pooled Analysis 63 Atypical Hemolytic Uremic Syndrome 63 Epithelial 63 Radical Prostatectomy 63 Study Showed 63 Advanced Melanoma 63 Abciximab 63 Adjuvant Therapy 63 Tolerability 63 Treatment Naive 63 Novel Oral 63 Acute Myocardial Infarction 63 Chronic Sinusitis 63 Topical Gel 63 Therapeutic Efficacy 63 Budesonide 63 Adalimumab 63 Adenoviral 63 HCV Genotype 63 Induction Therapy 63 Progressive Multifocal Leukoencephalopathy 63 Monoclonal Antibody 63 Mg Usa 63 Previously Untreated 63 Allogeneic 63 Proves Effective 63 Fulvestrant 63 Mg Uk 63 Cystectomy 63 Controlled Study 63 Neuroprotective Effects 63 Aerosolized 63 Increased Mortality 63 VAPRISOL 63 vapreotide acetate 63 Metastatic Prostate Cancer 63 Left Ventricular 63 Newly Diagnosed Multiple Myeloma 63 Beta Blocker 63 administered concomitantly 63 PEG IFN 63 Diabetic Patients 63 leukopenia pancytopenia thrombocytopenia 63 Toxicities 63 Randomized Double Blind 63 Plus Ribavirin 63 Treatment Naive Patients 63 Phase IIb Clinical Trial 63 Advanced Prostate Cancer 63 Advanced Colorectal Cancer 62 Bone Mineral Density 62 intravesical instillation 62 denileukin diftitox 62 cidofovir 62 Myelodysplastic Syndromes 62 Metabolic Efficiency 62 Placebo Controlled Study 62 Adjunctive 62 Dendritic Cells 62 Significant Efficacy 62 Demonstrated Significant 62 Gemcitabine 62 Chronic Hepatitis C 62 Left Atrial 62 murine model 62 Inhaled 62 Hepatic 62 Metastatic Melanoma 62 Pafuramidine 62 Aortic Valve Replacement 62 Transdermal Patch 62 Immunomodulatory 62 intramuscular 62 Cardiovascular Events 62 Soft Tissue Sarcoma 62 Drug Candidate 62 Doxorubicin 62 Coronary Artery Bypass Surgery 62 Oral Anticoagulant 62 dasatinib Sprycel ® 62 Combination Therapy 62 Azathioprine 62 Demonstrate Significant 62 IND Application 62 Cutaneous T 62 Neoplasms 62 Intracranial Aneurysms 62 unfractionated heparin UFH 62 lanreotide 62 Adefovir 62 Statistically Significant 62 Teriparatide 62 somatostatin analogue 62 Lubiprostone 62 Cervical Dystonia 62 Receives Orphan Drug Designation 62 Platinol ® 62 Endovascular Treatment 62 hydroxocobalamin 62 Squamous Cell Carcinoma 62 Epidermal Growth Factor Receptor 62 FDA Approvals 62 Tiotropium 62 8mg/kg 62 Linezolid 62 Radioimmunotherapy 62 Cutaneous 62 Intracerebral Hemorrhage 62 fluticasone furoate 62 Kidney Transplant Patients 62 Liver Failure 62 Demonstrates Positive 62 Disease Progression 62 Cytarabine 62 Pivotal Study 62 interleukin IL -# 62 Carotid Stenting 62 Relapsed 62 Levofloxacin 62 ara C 62 Heart Failure Patients 62 Metastatic Renal Cell Carcinoma 62 Carvedilol 62 Cryoablation 62 Immunogenic 62 Replacement Therapy 62 hypomagnesemia 62 Intravitreal 62 Anticoagulant 62 fondaparinux sodium 62 TNF Tumor Necrosis Factor 62 Medoxomil 62 Relapsed Refractory 62 Myelodysplastic Syndrome MDS 62 Plaque Psoriasis 62 Zorbtive TM 62 Demonstrates Potent 62 Tesamorelin 62 Glucocorticoid 62 Dose Escalation 62 Moxifloxacin 62 Hypercholesterolemia 62 Knee Osteoarthritis 62 Intravenous Formulation 62 docetaxel Taxotere ® 62 Seasonal Allergic Rhinitis 62 intra articular injection 62 CIMZIA TM 62 Accelerated Partial Breast Irradiation 62 Thrombotic 62 Dexamethasone 62 PEGylated Fab fragment 62 Protease Inhibitor 62 Nucleoside 62 4mg/kg 62 ribavirin RBV 62 sitagliptin phosphate 62 Prodrug 62 Hsp# Inhibitor 62 Hypotension 62 Fibrinogen 62 Atypical Antipsychotic 62 Diabetic Nephropathy 62 abacavir Ziagen 62 Treating Chronic 62 alpha 2a 61 cinacalcet 61 fallopian tube cancers 61 Initiate Clinical Trial 61 Clinical Outcome 61 Phase IIa Clinical Trial 61 Coronary Angiography 61 Improved Survival 61 Shows Promise Against 61 ISTODAX 61 Romiplostim 61 Thrombus 61 Recurrent Glioblastoma 61 Dasatinib 61 Interferon Alfa 61 Self Expanding Stent 61 Insulin Glargine 61 Primary Hypercholesterolemia 61 Human Monoclonal Antibody 61 Lipolysis 61 Resection 61 Smooth Muscle 61 Hepatocellular Carcinoma 61 Drug Eluting 61 deferoxamine 61 injected subcutaneously 61 Coronary Arteries 61 Sandostatin R 61 Rotavirus Vaccine 61 Significantly Improved 61 6 mercaptopurine 61 Intra Arterial 61 Daptomycin 61 Lenalidomide 61 Sustained Efficacy 61 Conjugated 61 Antigen Specific 61 intra arterial 61 Natalizumab 61 Telithromycin 61 Myocardial 61 Peripheral Arterial 61 Vincristine 61 Transdermal 61 Pulmonary Arterial Hypertension 61 Post Operative 61 Beneficial Effects 61 recombinant tissue plasminogen 61 octreotide acetate 61 R Saizen R 61 Anti Tumor 61 Carboplatin Paclitaxel 61 Attenuates 61 Urethral 61 Hematopoietic 61 ergot alkaloids 61 benzoic acid hyoscyamine sulfate 61 Treatment Naive HIV 61 Low Density Lipoprotein Cholesterol 61 Drug Resistant 61 Chronic Hepatitis B 61 administered intramuscularly 61 oral antidiabetic medication 61 selective A2A adenosine receptor 61 Inhibits 61 NDA Submission 61 Simulect 61 Meta Analysis 61 Lanthanum Carbonate 61 Induces 61 Osteoporosis Treatment 61 Carboplatin 61 Aneurysm Repair 61 GP IIb IIIa inhibitors 61 Follicular Lymphoma 61 Fibrin Sealant 61 Treatment Experienced 61 Refractory Angina 61 Treatment Resistant 61 Postmenopausal Women 61 Ultrasound Guided 61 Corticosteroid 61 Anti Inflammatory Drug 61 Endothelial 61 Leucovorin 61 sunitinib Sutent 61 Potent Anti 61 Inhaled Corticosteroids 61 CT Angiography 61 dual endothelin receptor antagonist 61 Malignant Glioma 61 intravenously administered 61 Secretory 61 Secondary Hyperparathyroidism 61 Dose Escalation Study 61 Kinase Inhibitor 61 VP# [004] 61 Endothelial Cells 61 Tumor Growth 61 MR Angiography 61 aspartate aminotransferase AST 61 Signaling Pathway 61 Kidney Function 61 Celecoxib 61 Fast Track Status 61 Partial Onset Seizures 61 Universal Flu Vaccine 61 Reduced Incidence 61 oral rivaroxaban 61 ORENCIA ® 61 Anticancer Drug 61 Completes Enrollment 61 prochlorperazine 61 Stenting 61 Capsules CII 61 GHRH 61 Novel Mechanism 61 Vivaglobin 61 Zileuton 61 Mylan Receives Approval 61 Gastrointestinal Tract 61 First Patient Dosed 61 FASLODEX 61 capsules USP 61 Cytotoxicity 61 intracoronary 61 Pramlintide 61 AnaSpec Introduces 61 Dosage Form 61 FDA Okays 61 Enzyme Replacement Therapy 61 Endometrial 61 meropenem 61 Duodenal 61 Intracranial 61 Generic Version 61 Aortic Valve 61 JAK Inhibitor 61 r hGH 61 J Am Coll 61 insulin glulisine 61 bleomycin 61 Intra articular 61 leiomyomas 61 Versus Placebo 61 Neoadjuvant 61 vinorelbine tartrate 61 Corneal Transplant 61 Vaprisol 60 Clinical Study Shows 60 Erlotinib 60 Abstract Number 60 Estrogen Receptor 60 Orthostatic Hypotension 60 Golimumab 60 Hepatitis B Vaccine 60 Kahalalide F 60 Investigational Treatment 60 RNAi Therapeutic 60 Tumor Necrosis Factor 60 Eluting Stent 60 Kinoid 60 methylprednisolone 60 Safinamide 60 Immune Globulin 60 complement inhibitor eculizumab 60 Anthracycline 60 Tigecycline 60 isoproterenol 60 dalteparin 60 Randomized Controlled 60 Clinical Study 60 Contrast Agents 60 Therapeutic Vaccine 60 Tolvaptan 60 Naive Patients 60 downregulates 60 Stable Angina 60 Fludarabine 60 HYCAMTIN 60 Carbamazepine 60 Renal Artery 60 Prostate Cancer Vaccine 60 subcutaneously administered 60 Vidaza azacitidine 60 Blood Pressure Lowering 60 Maleate 60 SCIg 60 Randomised 60 FUSILEV enhances 60 intratumoral 60 Effectively Treats 60 Induction Chemotherapy 60 Respiratory Virus 60 Solid Tumors 60 Carotid 60 Radiation Dose 60 Non Inferiority 60 Polymyxin B 60 Advanced Solid Tumors 60 Partial Seizures 60 pancrelipase 60 Double Blind Placebo 60 Dose Response 60 Ischemic 60 myopathy rhabdomyolysis 60 Study Demonstrates 60 Risedronate 60 First Patient Treated 60 milrinone 60 rHuPH# 60 Chemophase 60 icatibant 60 Infarct 60 Resistant Hypertension 60 Metronidazole 60 Vaccine Adjuvant 60 Oncolytic 60 PKC# 60 Randomized Evaluation 60 Files IND 60 Prostacyclin 60 MGd 60 Anti VEGF 60 severe neutropenia 60 ritonavir boosted 60 Cardiogenic Shock 60 Mitral Regurgitation 60 Stent Restenosis 60 prucalopride 60 Minimally Invasive Treatment 60 Antiplatelet 60 EUFLEXXA R 60 Phase 2a Trial 60 Degarelix 60 efavirenz EFV 60 Fracture Risk 60 colorectal liver metastases 60 Chronic Heart Failure 60 Sublingual 60 #F FDG 60 Tumor Targeting 60 Immunoglobulin 60 Levoleucovorin 60 rt PA 60 Trial Evaluating 60 Total Knee Arthroplasty 60 nicardipine 60 XYOTAX TM 60 FDA Accepts 60 Oral Insulin 60 Inactivation 60 Biphasic 60 Proteasome 60 Dose Finding 60 Vitro Activity 60 Sulfonylurea 60 Unresectable 60 Subgroup Analysis 60 Chemokine Receptor 60 Adjuvant Treatment 60 FOLFOX6 60 Excretion 60 Contraindications 60 TO AVOID PREGNANCY WHILE 60 Confirms Efficacy 60 HER2 Positive Breast Cancer 60 Immunogenicity 60 Node Positive 60 PROCRIT R 60 Adenoma 60 von Willebrand Factor 60 intravitreal 60 Valsartan 60 Treatment Regimen 60 Relapsed Multiple Myeloma 60 Retinoic Acid 60 Exacerbation 60 Intraocular 60 Pioglitazone 60 Diabetic Foot Ulcer 60 Inflammatory Pain 60 Antiviral Therapy 60 Orally administered 60 Tocilizumab 60 Shows Efficacy 60 alefacept 60 Polymerase Inhibitor 60 CIMZIA R 60 Bacteremia 60 Randomized Double blind 60 Restenosis 60 Inhaled Liposomal Ciprofloxacin 60 Carcinomas 60 Suppresses 60 bolus injection 60 topically administered 60 Ultrasonography 60 Conjugate 60 sufentanil 60 Regenerative Cells 60 intraperitoneally 60 Tumor Response 60 voriconazole 60 Receptor Agonist 60 Inhaled Nitric Oxide 60 subcutaneous immunoglobulin 60 Azacitidine 60 Neulasta ® 60 Antiangiogenic 60 Lupus Nephritis 60 busulfan 60 Albuferon TM 60 Malignant Melanoma 60 Disease Modifying 60 uricase 60 Venous Thromboembolism 60 Modulates 60 Multicenter Trial 60 Teva Provides Update 60 Montelukast 60 myelodysplastic myeloproliferative diseases 60 Mouse Model 60 Treatment Naïve 60 Neovascular Age Related Macular 60 flecainide 60 Seasonal Influenza Vaccine 60 Salmeterol 60 severe hypersensitivity reactions 60 sclerosing 60 Patients Enrolled 60 Tezampanel 60 BARACLUDE ® 60 interferon alfa 2b 60 Taclonex R 60 Darunavir 60 Acute Attacks 60 Verapamil 60 Dosed 60 Pivotal Clinical Trial 60 Docetaxel 60 Lansoprazole 60 Proven Effective 60 selective modulator 60 Cell Lymphoma 60 Shows Promising 60 Cholesterol Lowering Drug 60 Diuretic 60 Suppositories 60 Alveolar 60 Benign Prostatic Hyperplasia 60 Granted Orphan Drug 60 Ovidrel 60 Transdermal Delivery 60 vWF 60 Randomized Study 60 Electrical Stimulation 60 gastrointestinal stromal tumors GIST 60 Epoprostenol 60 Recurrent Ovarian Cancer 60 Randomized Phase 60 Angiogenic 59 biliary tract cancer 59 Histologic 59 Antithrombin 59 Ectopic 59 Randomized Phase II 59 #mg BID [001] 59 budesonide pMDI 59 Effective Than 59 Intravenous Immunoglobulin 59 metaplasia 59 Buccal 59 FDA Clearance 59 Chronic Constipation 59 Thiazolidinediones 59 Coronary Artery Bypass Graft 59 Doxil ® 59 Topotecan 59 ß blockers 59 Coronary Artery 59 C Reactive Protein 59 Critically Ill Patients 59 Demonstrates Significant 59 Carotid Endarterectomy 59 Diabetic Foot Ulcers 59 cromolyn sodium 59 Sustained Release 59 Embolic 59 Capsular 59 octreotide 59 Aeroquin 59 Clinical Evaluation 59 chemoradiation therapy 59 Cimetidine 59 Pivotal Phase 59 Cyclooxygenase 2 59 Robotic Assisted 59 Cypher Sirolimus 59 Demonstrates Sustained 59 Stenosis 59 Acute Decompensated Heart Failure 59 headache abdominal pain 59 Gonadotropin 59 Oral Formulation 59 Myocardial Ischemia 59 Morpholino 59 Alkaline Phosphatase 59 Thromboembolism 59 Lacosamide 59 Tumor Cells 59 Randomized Placebo Controlled Trial 59 sunitinib Sutent ® 59 malignant ascites 59 Drug Eluting Stents 59 stimulation PTNS 59 Ropinirole 59 Traficet EN 59 mesylate 59 intravenous bolus 59 tigecycline 59 Anticancer Drugs 59 Secretion 59 intraperitoneal injection 59 undergone cataract extraction 59 HDAC Inhibitor 59 Ablation 59 intranasal 59 Lymphoid 59 TNF Blockers 59 COZAAR 59 Grafts 59 Invasive Breast Cancer 59 Polyethylene Glycol 59 Myeloma Patients 59 Losartan 59 Carbidopa Levodopa 59 Phase III Trials 59 Dilatation 59 Abrupt discontinuation 59 Contrast Enhanced 59 aripiprazole Abilify 59 Tumor Progression 59 Drug Eluting Coronary Stent 59 Inhalation Aerosol 59 Diffuse Large B 59 Prognostic Factors 59 danazol 59 receiving VELCADE 59 Lung Cancer Trial 59 Indomethacin 59 Present Preclinical Data 59 amphotericin B 59 lopinavir r 59 Cethromycin 59 sorafenib Nexavar 59 Ondansetron Injection USP 59 Clinical Relevance 59 Receptor Antagonist 59 hepatoma 59 medroxyprogesterone acetate 59 β blockers 59 Fingolimod 59 azacytidine 59 Dalbavancin 59 selective antagonist 59 Data Suggest 59 Bendamustine 59 1mg 2mg 59 Tipranavir 59 Reduced Risk 59 Potent Inhibitor 59 Sirolimus Eluting Stent 59 bolus dose 59 Ezetimibe 59 postoperative inflammation 59 ORLive Presents 59 Malignancies 59 Carcinoma 59 rhEPO 59 transurethral 59 Infarction 59 Valvular 59 Balloon Catheter 59 palifermin 59 PRN FDA Approves 59 Bypass Surgery 59 Obese Patients 59 Randomized Trials 59 amikacin 59 tolterodine ER 59 Valopicitabine NM# 59 epoetin alfa 59 Gamunex C 59 Liver Metastases 59 Ganciclovir 59 Severe Asthma 59 Metastases 59 Initiates Clinical 59 Allografts 59 HCV Protease Inhibitor 59 Osteoporosis Drug 59 Long Term Outcomes 59 Chronic Myeloid Leukemia 59 Gastric Cancer 59 Pharmacokinetics 59 rilonacept 59 Cardiopulmonary Bypass 59 gonadotropin releasing hormone GnRH 59 Nitazoxanide 59 Vascular Grafts 59 q#h 59 Efficacy Trial 59 Protease Inhibitors 59 Chemotherapy Induced 59 Ischemic Stroke 59 Multicenter Randomized Double 59 Somatostatin 59 Radezolid 59 Smallpox Vaccine 59 Angiotensin Converting Enzyme 59 Hypertrophy 59 intracavitary 59 R lenalidomide 59 Orally Active 59 miconazole 59 Ecallantide 59 systemic corticosteroid 59 Small Molecule 59 Peginterferon Alfa 2b 59 Shows Statistically Significant 59 Uterine 59 Osteoporosis Drugs 59 Premature Infants 59 acitretin 59 Concomitant 59 administered intranasally 59 rFVIIa 59 IN PATIENTS WITH 59 pT2 59 Papillary 59 verteporfin 59 Cytotoxic 59 phenyl salicylate methylene blue 59 Clinically Proven 59 vecuronium 59 Femtosecond Laser 59 Invasive Fungal Infections 59 liposomal amphotericin B 59 Pharmacokinetic 59 FDA Approves 59 Pivotal Trials 59 Tyrosine Kinase Inhibitors 59 Advanced Pancreatic Cancer 59 Relapsed Refractory Multiple Myeloma 59 dihydroergotamine 59 Potentially Fatal 59 Camptosar ® 59 Dapagliflozin 59 intra articular 59 Clostridium difficile Infection 59 Aortic Stenosis 59 Axillary 59 Darbepoetin Alfa 59 Cell Proliferation 59 Neoadjuvant Chemotherapy 59 tumor lysate 59 Who Underwent 59 Pulmonary Artery 59 nebulization 59 Vaccine Candidate 59 Randomized Double Blind Placebo 59 Anticancer Activity 59 Uric Acid 59 Uterine Fibroid Embolization 59 Cardiovascular Outcomes 59 Atomoxetine 59 Nodules 59 hypertrophic scarring 59 aminophylline 59 THERMOCOOL R 59 #beta estradiol 59 Combination REOLYSIN R 59 erlotinib Tarceva ® 59 infusional 59 amprenavir 59 Platelet Inhibition 59 Indacaterol 59 ATACAND 59 pharmacokinetic interactions 59 Vertebroplasty 59 Zoledronic acid 59 Kamada AAT 59 INFERGEN 59 superficial bladder cancer 59 Nasal Spray 59 beta 1a 59 Randomized Controlled Trial 59 continuous intravenous infusion 59 Cancer Cells 59 basiliximab 59 salmeterol fluticasone 59 Hypertrophic 59 timolol maleate 59 corticosteroid therapy 59 immunocompetent patients 59 carmustine 59 Contrast Agent 59 Dabigatran etexilate 58 Fewer Side Effects 58 cisplatin gemcitabine 58 MYCAMINE 58 Randomized Clinical Trials 58 Myeloid 58 Linagliptin 58 moderate hepatic impairment 58 Treat Anemia 58 systemic hypotension 58 PEGASYS ® 58 ketorolac 58 Imiquimod 58 Angina pectoris 58 Systemic Sclerosis 58 Topical Cream 58 Hepatocytes 58 elevated transaminases 58 clomipramine 58 BAL# [002]

Back to home page